Metabolic Blueprint Stack (Half)

Retatrutide is an advanced triple-agonist peptide currently under investigation for its potential to revolutionize metabolic health. It activates GLP-1, GIP, and glucagon receptors, providing a multi-pronged approach to weight loss, appetite regulation, and energy expenditure. Early research suggests it could achieve greater fat loss than current GLP-1 therapies while improving cardiovascular and metabolic markers.Its triple-receptor activity makes it one of the most promising new peptides for obesity management and overall metabolic optimization.

MOTS-c is a mitochondrial-derived peptide that plays a vital role in regulating energy production, improving metabolic flexibility, and enhancing exercise performance. By activating the AMPK pathway, it supports fat oxidation, glucose regulation, and cellular resilience, making it a powerful ally in longevity and anti-aging protocols. Research suggests that MOTS-c can improve endurance, reduce insulin resistance, and help counteract age-related metabolic decline. It is often paired with other longevity peptides for a synergistic effect.

CJC-1295 DAC is a long-acting analog of growth hormone-releasing hormone (GHRH), designed to stimulate the natural production of GH and IGF-1. With its DAC (Drug Affinity Complex) modification, CJC-1295 offers a prolonged half-life, allowing for sustained GH release over several days from a single dose. This peptide is widely used in anti-aging, athletic performance, and fat-burning regimens. It encourages deep sleep, cellular regeneration, improved lean body mass, and faster recovery from exercise or injury. When paired with GHRPs like Ipamorelin, CJC-1295 DAC creates a synergistic GH surge for enhanced results. Its extended activity and low injection frequency make it a popular option for individuals seeking convenience without compromising effectiveness.